Walmart settled a federal opioid lawsuit this week. The Justice Department accused the retailer of violating the Controlled Substances Act since 2013. That's thirteen years of allegedly filling prescriptions without proper oversight. Thirteen years is longer than most retail traders hold a position, but shorter than the time it takes them to admit they were wrong.
The complaint centered on Walmart's pharmacies dispensing controlled substances illegally. Apparently someone at corporate forgot that selling Vicodin requires more paperwork than restocking the Great Value potato chips. The federal government noticed. Filed suit in 2020. Took six years to wrap up. Nothing says urgent public health crisis like a half-decade negotiation.
Walmart operates over 5,000 pharmacies nationwide. Each one staffed by actual licensed pharmacists who definitely knew the rules. But the algorithms said fill faster, move volume, hit metrics. And when corporate sets the KPIs, compliance becomes someone else's problem. Specifically, it became the Justice Department's problem.
The settlement amount wasn't disclosed in the summary. Probably because Walmart considers it a rounding error. They'll pay the fine, issue a statement about enhanced protocols, and train managers on a new module titled "Why Federal Drug Laws Apply To Us Too." Then everyone goes back to work. The pharmacists keep filling scripts. The government cashes the check. And retail traders will somehow find a way to lose money on puts and calls simultaneously.
This is what passes for accountability now. A company allegedly breaks federal drug laws for over a decade. Gets sued. Settles without admitting wrongdoing. The stock doesn't even blink. Because the market already priced in that Walmart would eventually monetize America's painkiller addiction, one way or another. The only surprise is that anyone pretended to be surprised.
Your neighbor Steve definitely bought the dip on this news, convinced it was a buying opportunity.
Photo by on Unsplash
Leave a Comment